These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 24116693

  • 1. Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study.
    Alloin AL, Barlogis V, Auquier P, Contet A, Poiree M, Demeocq F, Herrmann I, Villes V, Bertrand Y, Plantaz D, Kanold J, Chastagner P, Chambost H, Sirvent N, Michel G.
    Br J Haematol; 2014 Jan; 164(1):94-100. PubMed ID: 24116693
    [Abstract] [Full Text] [Related]

  • 2. Incidence and risk factors for cataract after haematopoietic stem cell transplantation for childhood leukaemia: an LEA study.
    Horwitz M, Auquier P, Barlogis V, Contet A, Poiree M, Kanold J, Bertrand Y, Plantaz D, Galambrun C, Berbis J, Villes V, Chastagner P, Sirvent N, Oudin C, Michel G.
    Br J Haematol; 2015 Feb; 168(4):518-25. PubMed ID: 25284463
    [Abstract] [Full Text] [Related]

  • 3. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT, Sabin ND, Reddick WE, Bhojwani D, Liu W, Brinkman TM, Glass JO, Hwang SN, Srivastava D, Pui CH, Robison LL, Hudson MM, Krull KR.
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [Abstract] [Full Text] [Related]

  • 4. Moyamoya syndrome following childhood acute lymphoblastic leukemia.
    Kikuchi A, Maeda M, Hanada R, Okimoto Y, Ishimoto K, Kaneko T, Ikuta K, Tsuchida M, Tokyo Children's Cancer Study Group (TCCSG).
    Pediatr Blood Cancer; 2007 Mar; 48(3):268-72. PubMed ID: 16615044
    [Abstract] [Full Text] [Related]

  • 5. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
    Langer T, Martus P, Ottensmeier H, Hertzberg H, Beck JD, Meier W.
    Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
    [Abstract] [Full Text] [Related]

  • 6. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P, Mulhern RK, Regine WF, Rivera GK, Kun LE.
    Int J Radiat Oncol Biol Phys; 1995 Feb 01; 31(3):561-6. PubMed ID: 7852120
    [Abstract] [Full Text] [Related]

  • 7. The neurodevelopmental sequelae of childhood leukaemia and its treatment.
    Temming P, Jenney ME.
    Arch Dis Child; 2010 Nov 01; 95(11):936-40. PubMed ID: 20980277
    [Abstract] [Full Text] [Related]

  • 8. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
    Sancho JM, Ribera JM, Oriol A, Hernandez-Rivas JM, Rivas C, Bethencourt C, Parody R, Deben G, Bello JL, Feliu E, Programa para el Estudio y Tratamiento de Hemopatias Malignas Group.
    Cancer; 2006 Jun 15; 106(12):2540-6. PubMed ID: 16700036
    [Abstract] [Full Text] [Related]

  • 9. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P, Kun LE, Hustu HO, Mulhern RK, Hancock ML, Coffey D, Rivera GK.
    Int J Radiat Oncol Biol Phys; 1995 Feb 01; 31(3):477-83. PubMed ID: 7852109
    [Abstract] [Full Text] [Related]

  • 10. Analysis of growth failure in children treated for acute lymphoblastic leukemia.
    Sato J, Ninomiya T, Tsuda Y, Komazawa M, Nagata K, Iwai A, Nishikawa K, Maeda H, Ohmiya A, Ohta M.
    Int J Hematol; 1992 Dec 01; 56(3):205-12. PubMed ID: 1477332
    [Abstract] [Full Text] [Related]

  • 11. Health status and quality of life of long-term survivors of childhood acute leukemia: the impact of central nervous system irradiation.
    Benadiba J, Michel G, Auquier P, Chastagner P, Kanold J, Poirée M, Plantaz D, Padovani L, Berbis J, Barlogis V, Contet A, Chambost H, Sirvent N.
    J Pediatr Hematol Oncol; 2015 Mar 01; 37(2):109-16. PubMed ID: 24936742
    [Abstract] [Full Text] [Related]

  • 12. Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia.
    Lin WY, Liu HC, Yeh TC, Wang LY, Liang DC.
    Pediatr Blood Cancer; 2008 Mar 01; 50(3):523-7. PubMed ID: 17455314
    [Abstract] [Full Text] [Related]

  • 13. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
    Veerman AJ, Kamps WA, van den Berg H, van den Berg E, Bökkerink JP, Bruin MC, van den Heuvel-Eibrink MM, Korbijn CM, Korthof ET, van der Pal K, Stijnen T, van Weel Sipman MH, van Weerden JF, van Wering ER, van der Does-van den Berg A, Dutch Childhood Oncology Group.
    Lancet Oncol; 2009 Oct 01; 10(10):957-66. PubMed ID: 19747876
    [Abstract] [Full Text] [Related]

  • 14. Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia.
    Edelstein K, D'agostino N, Bernstein LJ, Nathan PC, Greenberg ML, Hodgson DC, Millar BA, Laperriere N, Spiegler BJ.
    J Pediatr Hematol Oncol; 2011 Aug 01; 33(6):450-8. PubMed ID: 21646917
    [Abstract] [Full Text] [Related]

  • 15. Current management and challenges of malignant disease in the CNS in paediatric leukaemia.
    Pui CH, Howard SC.
    Lancet Oncol; 2008 Mar 01; 9(3):257-68. PubMed ID: 18308251
    [Abstract] [Full Text] [Related]

  • 16. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi A, Miniero R, Di Tullio MT, Lo Nigro L, Pession A, Rondelli R, Messina C, Santoro N, Mori PG, De Rossi G, Tamaro P, Silvestri D, Biondi A, Basso G, Masera G.
    Haematologica; 1998 Sep 01; 83(9):791-9. PubMed ID: 9825576
    [Abstract] [Full Text] [Related]

  • 17. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
    Waber DP, Turek J, Catania L, Stevenson K, Robaey P, Romero I, Adams H, Alyman C, Jandet-Brunet C, Neuberg DS, Sallan SE, Silverman LB.
    J Clin Oncol; 2007 Nov 01; 25(31):4914-21. PubMed ID: 17971588
    [Abstract] [Full Text] [Related]

  • 18. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.
    Schmiegelow K, Forestier E, Hellebostad M, Heyman M, Kristinsson J, Söderhäll S, Taskinen M, Nordic Society of Paediatric Haematology and Oncology.
    Leukemia; 2010 Feb 01; 24(2):345-54. PubMed ID: 20010622
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.
    Biol Blood Marrow Transplant; 2008 Jun 01; 14(6):685-92. PubMed ID: 18489994
    [Abstract] [Full Text] [Related]

  • 20. Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity.
    Waber DP, Silverman LB, Catania L, Mautz W, Rue M, Gelber RD, Levy DE, Goldwasser MA, Adams H, Dufresne A, Metzger V, Romero I, Tarbell NJ, Dalton VK, Sallan SE.
    J Clin Oncol; 2004 Jul 01; 22(13):2701-7. PubMed ID: 15226337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.